Sabby Management, LLC Adverum Biotechnologies, Inc. Transaction History

Sabby Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$4.5 - $7.6 $122,683 - $207,198	-27,263 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$5.3 - $6.9 $910,015 - $1.18 Million	-171,701 Reduced 86.3%	27,263 $144,000
Q1 2018 May 15, 2018	SELL	$3.65 - $7.95 $368,781 - $803,236	-101,036 Reduced 33.68%	198,964 $1.15 Million
Q4 2017 Feb 14, 2018	BUY	$2.85 - $3.95 $855,000 - $1.19 Million	300,000	300,000 $1.05 Million

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.